Infectious Diseases (except HIV/AIDS)
Showing page 306 of 716 pages of list content
-
MITIGATING THE 4 th WAVE OF THE COVID-19 PANDEMIC IN ONTARIO
This article's authors -
Lab-on-a-chip multiplexed electrochemical sensor enables simultaneous detection of SARS-CoV-2 RNA and host antibodies
This article's authors -
Effectiveness of inactive COVID-19 vaccines against severe illness in B.1.617.2 (Delta) variant-infected patients in Jiangsu, China
This article's authors -
A third dose of inactivated vaccine augments the potency, breadth, and duration of anamnestic responses against SARS-CoV-2
This article's authors -
Comparative quantitative analysis of SARS- CoV-2 Spike neutralizing antibody titers following two anti COVID-19 vaccines in India
This article's authors -
The comparability of Anti-Spike SARS-CoV-2 antibody tests is time-dependent: a prospective observational study
This article's authors -
No difference in risk of hospitalisation between reported cases of the SARS-CoV-2 Delta variant and Alpha variant in Norway
This article's authors -
Wastewater-Based Epidemiology and Whole-Genome Sequencing for Community-Level Surveillance of SARS-CoV-2 in Selected Urban Communities of Davao City, Philippines: A Pilot Study
This article's authors -
Effectiveness of COVID-19 Vaccines Against SARS-CoV-2 Infection During a Delta Variant Epidemic Surge in Multnomah County, Oregon, July 2021
This article's authors -
Sars-Cov-2 antibody titer 3 months post-vaccination is affected by age, gender, smoking and vitamin D
This article's authors